Featured Conference
4th Annual Summit on Post-Marketing Studies
Design Post-Approval Studies for Improved Safety and Risk Assessment while Meeting Clinical, Marketing and Regulatory Objectives
February 4 – 5, 2008 * London, United Kingdom
For more information or to register, please visit the conference website.
Visit this Pharma Marketing Events Forum discussion thread for up-to-date notices, program details, speaker changes, etc.
The Definitive Annual Forum for Providing Reliable Up-to-Date Information on Post-Marketing Studies
Over 300 pharmaceutical executives have attended the only forum dedicated entirely to addressing post-marketing study issues in Europe. CBI’s Annual summit provides industry leaders with current strategies for designing and conducting successful Phase IV studies, patient registries and epidemiologic studies.
Topics being discussed for 2008 include:
- Achieving success with non-interventional studies without harmonized regulations
- Utilising IIS studies for new indications and increasing market access
- Creating a balance between post-marketing patient data collection and quality of an observational study in the absence of GCP guidelines
- Effective data collection strategies for meeting Research and Development and marketing needs
- Exploring some of the limitations regarding publications of post-marketing data and provide case examples for leveraging new opportunities and channels in the publication strategy
Network at, and benefit from, the leading industry event!
Hear what some of our previous attendees had to say:
“The CBI conference is a good platform for professionals to meet and discuss topics related to post-marketing activities and a good conference for newcomers to then develop the knowledge on the best practices in this area.”
— Mariloa Rakowska, Medical Affairs, Sanofi-Aventis
“An excellent conference on post-marketing studies with a great programme and high-level audience.”
— Francis P. Crawley, Director General, Good Clinical Practice Alliance, Europe and Member, Scientific Advisory Group, International Clinical Trials Registry Platform, World Health Organization
“Provided a sound framework for constructive discussions among key industry figures in post-marketing studies.”
— Gerry Downey, Biostatistics Manager, Amgen
“Well organized and balanced conference content and networking opportunities.”
— Gurdyal Kalsi, M.D., Global Head of Safety, MDS Inc.
“I do believe in increasing importance of post-marketing studies especially in light of new requirements, pharmaceutical industry has to face, concerning the preparation and management of Risk Management Plans for new products. The CBI conference is a good platform for professionals to meet and discuss topics related to post-marketing activities and a good conference for newcomers and then developed the knowledge on the best practices in this area.”
— Mariloa Rakowska, Medical Affairs, Sanofi-Aventis
For more information or to register, please please visit the conference website or contact the Center for Business Intelligence toll free by phone at 1-800-817-8601 or via e-mail at cbireg@cbinet.com.
